Type |
Details |
Score |
Gene |
Type: |
gene |
Organism: |
human |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
cattle |
|
•
•
•
•
•
|
Gene |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
dog, domestic |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
chimpanzee |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
zebrafish |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
macaque, rhesus |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
frog, western clawed |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
cat, domestic |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
chicken |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Publication |
First Author: |
Chang HY |
Year: |
1987 |
Journal: |
Oncogene Res |
Title: |
Mouse N-ras genes: organization of the functional locus and of a truncated cDNA-like pseudogene. |
Volume: |
1 |
Issue: |
2 |
Pages: |
129-36 |
|
•
•
•
•
•
|
Publication |
First Author: |
Burd CE |
Year: |
2014 |
Journal: |
Cancer Discov |
Title: |
Mutation-specific RAS oncogenicity explains NRAS codon 61 selection in melanoma. |
Volume: |
4 |
Issue: |
12 |
Pages: |
1418-29 |
|
•
•
•
•
•
|
Publication |
First Author: |
Takahashi C |
Year: |
2006 |
Journal: |
Nat Genet |
Title: |
Nras loss induces metastatic conversion of Rb1-deficient neuroendocrine thyroid tumor. |
Volume: |
38 |
Issue: |
1 |
Pages: |
118-23 |
|
•
•
•
•
•
|
Publication |
First Author: |
Murphy BM |
Year: |
2022 |
Journal: |
Nat Commun |
Title: |
Enhanced BRAF engagement by NRAS mutants capable of promoting melanoma initiation. |
Volume: |
13 |
Issue: |
1 |
Pages: |
3153 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ren JG |
Year: |
2023 |
Journal: |
J Clin Invest |
Title: |
RAB27B controls palmitoylation-dependent NRAS trafficking and signaling in myeloid leukemia. |
Volume: |
133 |
Issue: |
12 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Kwong LN |
Year: |
2012 |
Journal: |
Nat Med |
Title: |
Oncogenic NRAS signaling differentially regulates survival and proliferation in melanoma. |
Volume: |
18 |
Issue: |
10 |
Pages: |
1503-10 |
|
•
•
•
•
•
|
Publication |
First Author: |
Nozawa A |
Year: |
2024 |
Journal: |
Hum Mol Genet |
Title: |
Lymphatic endothelial cell-specific NRAS p.Q61R mutant embryos show abnormal lymphatic vessel morphogenesis. |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Wiesner SM |
Year: |
2005 |
Journal: |
Blood |
Title: |
Repressible transgenic model of NRAS oncogene-driven mast cell disease in the mouse. |
Volume: |
106 |
Issue: |
3 |
Pages: |
1054-62 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kong G |
Year: |
2016 |
Journal: |
Leukemia |
Title: |
The ability of endogenous Nras oncogenes to initiate leukemia is codon-dependent. |
Volume: |
30 |
Issue: |
9 |
Pages: |
1935-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lassen LB |
Year: |
2012 |
Journal: |
PLoS One |
Title: |
Nras overexpression results in granulocytosis, T-cell expansion and early lethality in mice. |
Volume: |
7 |
Issue: |
8 |
Pages: |
e42216 |
|
•
•
•
•
•
|
Publication |
First Author: |
BallarÃn-González B |
Year: |
2013 |
Journal: |
PLoS One |
Title: |
Deregulated Nras expression in knock-in animals harboring a gammaretroviral long terminal repeat at the Nras/Csde1 locus. |
Volume: |
8 |
Issue: |
2 |
Pages: |
e56029 |
|
•
•
•
•
•
|
Publication |
First Author: |
Li Q |
Year: |
2013 |
Journal: |
Nature |
Title: |
Oncogenic Nras has bimodal effects on stem cells that sustainably increase competitiveness. |
Volume: |
504 |
Issue: |
7478 |
Pages: |
143-147 |
|
•
•
•
•
•
|
Publication |
First Author: |
Pawlikowski JS |
Year: |
2015 |
Journal: |
J Invest Dermatol |
Title: |
Acute Inhibition of MEK Suppresses Congenital Melanocytic Nevus Syndrome in a Murine Model Driven by Activated NRAS and Wnt Signaling. |
Volume: |
135 |
Issue: |
8 |
Pages: |
2093-2101 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kunimoto H |
Year: |
2018 |
Journal: |
Cancer Cell |
Title: |
Cooperative Epigenetic Remodeling by TET2 Loss and NRAS Mutation Drives Myeloid Transformation and MEK Inhibitor Sensitivity. |
Volume: |
33 |
Issue: |
1 |
Pages: |
44-59.e8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wang J |
Year: |
2011 |
Journal: |
Blood |
Title: |
Endogenous oncogenic Nras mutation initiates hematopoietic malignancies in a dose- and cell type-dependent manner. |
Volume: |
118 |
Issue: |
2 |
Pages: |
368-79 |
|
•
•
•
•
•
|
Publication |
First Author: |
Shi X |
Year: |
2019 |
Journal: |
BMC Cancer |
Title: |
Cooperation of Dnmt3a R878H with Nras G12D promotes leukemogenesis in knock-in mice: a pilot study. |
Volume: |
19 |
Issue: |
1 |
Pages: |
1072 |
|
•
•
•
•
•
|
Publication |
First Author: |
Rajagopalan A |
Year: |
2023 |
Journal: |
J Clin Invest |
Title: |
A gain-of-function p53 mutant synergizes with oncogenic NRAS to promote acute myeloid leukemia in mice. |
Volume: |
133 |
Issue: |
24 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Wen Z |
Year: |
2021 |
Journal: |
Blood |
Title: |
Nras Q61R/+ and Kras-/- cooperate to downregulate Rasgrp1 and promote lympho-myeloid leukemia in early T-cell precursors. |
Volume: |
137 |
Issue: |
23 |
Pages: |
3259-3271 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wang J |
Year: |
2010 |
Journal: |
Blood |
Title: |
Endogenous oncogenic Nras mutation promotes aberrant GM-CSF signaling in granulocytic/monocytic precursors in a murine model of chronic myelomonocytic leukemia. |
Volume: |
116 |
Issue: |
26 |
Pages: |
5991-6002 |
|
•
•
•
•
•
|
Publication |
First Author: |
Pedersen M |
Year: |
2013 |
Journal: |
Cancer Discov |
Title: |
Primary melanoma of the CNS in children is driven by congenital expression of oncogenic NRAS in melanocytes. |
Volume: |
3 |
Issue: |
4 |
Pages: |
458-469 |
|
•
•
•
•
•
|
Publication |
First Author: |
You X |
Year: |
2022 |
Journal: |
Blood |
Title: |
Asxl1 loss cooperates with oncogenic Nras in mice to reprogram the immune microenvironment and drive leukemic transformation. |
Volume: |
139 |
Issue: |
7 |
Pages: |
1066-1079 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fuentes-Mateos R |
Year: |
2019 |
Journal: |
Cell Death Dis |
Title: |
Concomitant deletion of HRAS and NRAS leads to pulmonary immaturity, respiratory failure and neonatal death in mice. |
Volume: |
10 |
Issue: |
11 |
Pages: |
838 |
|
•
•
•
•
•
|
Publication |
First Author: |
Guerrero I |
Year: |
1985 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Loss of the normal N-ras allele in a mouse thymic lymphoma induced by a chemical carcinogen. |
Volume: |
82 |
Issue: |
23 |
Pages: |
7810-4 |
|
•
•
•
•
•
|
Publication |
First Author: |
Coleman DJ |
Year: |
2015 |
Journal: |
Mol Cancer Res |
Title: |
Loss of keratinocytic RXRα combined with activated CDK4 or oncogenic NRAS generates UVB-induced melanomas via loss of p53 and PTEN in the tumor microenvironment. |
Volume: |
13 |
Issue: |
1 |
Pages: |
186-96 |
|
•
•
•
•
•
|
Publication |
First Author: |
Giannou AD |
Year: |
2017 |
Journal: |
EMBO Mol Med |
Title: |
NRAS destines tumor cells to the lungs. |
Volume: |
9 |
Issue: |
5 |
Pages: |
672-686 |
|
•
•
•
•
•
|
UniProt Feature |
Begin: |
1 |
Description: |
GTPase NRas |
Type: |
chain |
End: |
186 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ragab N |
Year: |
2021 |
Journal: |
Int J Mol Sci |
Title: |
Oncogenic NRAS Accelerates Rhabdomyosarcoma Formation When Occurring within a Specific Time Frame during Tumor Development in Mice. |
Volume: |
22 |
Issue: |
24 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Wen Z |
Year: |
2021 |
Journal: |
Blood |
Title: |
Expression of NrasQ61R and MYC transgene in germinal center B cells induces a highly malignant multiple myeloma in mice. |
Volume: |
137 |
Issue: |
1 |
Pages: |
61-74 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kong G |
Year: |
2016 |
Journal: |
Leukemia |
Title: |
Loss of wild-type Kras promotes activation of all Ras isoforms in oncogenic Kras-induced leukemogenesis. |
Volume: |
30 |
Issue: |
7 |
Pages: |
1542-51 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kim WI |
Year: |
2009 |
Journal: |
Blood |
Title: |
RAS oncogene suppression induces apoptosis followed by more differentiated and less myelosuppressive disease upon relapse of acute myeloid leukemia. |
Volume: |
113 |
Issue: |
5 |
Pages: |
1086-96 |
|
•
•
•
•
•
|
Publication |
First Author: |
McDaniel CG |
Year: |
2025 |
Journal: |
Pediatr Blood Cancer |
Title: |
Lyve1-Driven Nras(Q61R) Causes Edema, Enlarged Lymphatic Vessels, and Hepatic Vascular Defects in Embryonic Mice. |
Volume: |
72 |
Issue: |
3 |
Pages: |
e31492 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mangues R |
Year: |
1990 |
Journal: |
Oncogene |
Title: |
Tumorigenesis and male sterility in transgenic mice expressing a MMTV/N-ras oncogene. |
Volume: |
5 |
Issue: |
10 |
Pages: |
1491-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mediavilla MD |
Year: |
1997 |
Journal: |
J Pineal Res |
Title: |
Effects of melatonin on mammary gland lesions in transgenic mice overexpressing N-ras proto-oncogene. |
Volume: |
22 |
Issue: |
2 |
Pages: |
86-94 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mangues R |
Year: |
1992 |
Journal: |
Oncogene |
Title: |
Overexpression of the N-ras proto-oncogene, not somatic mutational activation, associated with malignant tumors in transgenic mice. |
Volume: |
7 |
Issue: |
10 |
Pages: |
2073-6 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mangues R |
Year: |
1998 |
Journal: |
Cancer Res |
Title: |
Antitumor effect of a farnesyl protein transferase inhibitor in mammary and lymphoid tumors overexpressing N-ras in transgenic mice. |
Volume: |
58 |
Issue: |
6 |
Pages: |
1253-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Dorard C |
Year: |
2017 |
Journal: |
Nat Commun |
Title: |
RAF proteins exert both specific and compensatory functions during tumour progression of NRAS-driven melanoma. |
Volume: |
8 |
|
Pages: |
15262 |
|
•
•
•
•
•
|
Publication |
First Author: |
You X |
Year: |
2018 |
Journal: |
Blood |
Title: |
Unique dependence on Sos1 in Kras G12D -induced leukemogenesis. |
Volume: |
132 |
Issue: |
24 |
Pages: |
2575-2579 |
|
•
•
•
•
•
|
Publication |
First Author: |
Assenmacher CA |
Year: |
2021 |
Journal: |
J Histochem Cytochem |
Title: |
Classification and Grading of Melanocytic Lesions in a Mouse Model of NRAS-driven Melanomagenesis. |
Volume: |
69 |
Issue: |
3 |
Pages: |
203-218 |
|
•
•
•
•
•
|
Publication |
First Author: |
Li A |
Year: |
2012 |
Journal: |
J Invest Dermatol |
Title: |
Activated mutant NRas(Q61K) drives aberrant melanocyte signaling, survival, and invasiveness via a Rac1-dependent mechanism. |
Volume: |
132 |
Issue: |
11 |
Pages: |
2610-21 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wang J |
Year: |
2013 |
Journal: |
Blood |
Title: |
Nras(G12D/+) promotes leukemogenesis by aberrantly regulating hematopoietic stem cell functions. |
Volume: |
121 |
Issue: |
26 |
Pages: |
5203-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wang Y |
Year: |
2013 |
Journal: |
Cancer Discov |
Title: |
Mutant N-RAS protects colorectal cancer cells from stress-induced apoptosis and contributes to cancer development and progression. |
Volume: |
3 |
Issue: |
3 |
Pages: |
294-307 |
|
•
•
•
•
•
|
Publication |
First Author: |
Campagne C |
Year: |
2017 |
Journal: |
Cell Signal |
Title: |
RACK1 cooperates with NRASQ61K to promote melanoma in vivo. |
Volume: |
36 |
|
Pages: |
255-266 |
|
•
•
•
•
•
|
Publication |
First Author: |
Souroullas GP |
Year: |
2016 |
Journal: |
Nat Med |
Title: |
An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation. |
Volume: |
22 |
Issue: |
6 |
Pages: |
632-40 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zambetti NA |
Year: |
2020 |
Journal: |
Blood |
Title: |
Genetic disruption of N-RasG12D palmitoylation perturbs hematopoiesis and prevents myeloid transformation in mice. |
Volume: |
135 |
Issue: |
20 |
Pages: |
1772-1782 |
|
•
•
•
•
•
|
Publication |
First Author: |
Li Q |
Year: |
2011 |
Journal: |
Blood |
Title: |
Hematopoiesis and leukemogenesis in mice expressing oncogenic NrasG12D from the endogenous locus. |
Volume: |
117 |
Issue: |
6 |
Pages: |
2022-32 |
|
•
•
•
•
•
|
Publication |
First Author: |
Xu J |
Year: |
2013 |
Journal: |
Cancer Discov |
Title: |
Dominant role of oncogene dosage and absence of tumor suppressor activity in Nras-driven hematopoietic transformation. |
Volume: |
3 |
Issue: |
9 |
Pages: |
993-1001 |
|
•
•
•
•
•
|
Publication |
First Author: |
Burgess MR |
Year: |
2014 |
Journal: |
Blood |
Title: |
Preclinical efficacy of MEK inhibition in Nras-mutant AML. |
Volume: |
124 |
Issue: |
26 |
Pages: |
3947-55 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kong G |
Year: |
2014 |
Journal: |
J Clin Invest |
Title: |
Combined MEK and JAK inhibition abrogates murine myeloproliferative neoplasm. |
Volume: |
124 |
Issue: |
6 |
Pages: |
2762-73 |
|
•
•
•
•
•
|
Publication |
First Author: |
Dong Y |
Year: |
2019 |
Journal: |
Cells |
Title: |
Synergy of NUP98-HOXA10 Fusion Gene and NrasG12D Mutation Preserves the Stemness of Hematopoietic Stem Cells on Culture Condition. |
Volume: |
8 |
Issue: |
9 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Rahman H |
Year: |
2021 |
Journal: |
J Invest Dermatol |
Title: |
Aspirin Protects Melanocytes and Keratinocytes against UVB-Induced DNA Damage In Vivo. |
Volume: |
141 |
Issue: |
1 |
Pages: |
132-141.e3 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
189
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
193
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
150
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
183
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
74
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
46
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Buchberg AM |
Year: |
1989 |
Journal: |
Genomics |
Title: |
Localization of the murine macrophage colony-stimulating factor gene to chromosome 3 using interspecific backcross analysis. |
Volume: |
5 |
Issue: |
2 |
Pages: |
363-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Slape C |
Year: |
2008 |
Journal: |
Blood |
Title: |
Leukemic transformation in mice expressing a NUP98-HOXD13 transgene is accompanied by spontaneous mutations in Nras, Kras, and Cbl. |
Volume: |
112 |
Issue: |
5 |
Pages: |
2017-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Pastura P |
Year: |
2024 |
Journal: |
Pediatr Blood Cancer |
Title: |
NRAS(Q61R) mutation drives elevated angiopoietin-2 expression in human endothelial cells and a genetic mouse model. |
Volume: |
71 |
Issue: |
7 |
Pages: |
e31032 |
|
•
•
•
•
•
|
Publication |
First Author: |
Haigis KM |
Year: |
2008 |
Journal: |
Nat Genet |
Title: |
Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colon. |
Volume: |
40 |
Issue: |
5 |
Pages: |
600-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Newlaczyl AU |
Year: |
2017 |
Journal: |
Sci Rep |
Title: |
Quantification of spatiotemporal patterns of Ras isoform expression during development. |
Volume: |
7 |
|
Pages: |
41297 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lyons PA |
Year: |
2001 |
Journal: |
Diabetes |
Title: |
Mapping by genetic interaction: high-resolution congenic mapping of the type 1 diabetes loci Idd10 and Idd18 in the NOD mouse. |
Volume: |
50 |
Issue: |
11 |
Pages: |
2633-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Choi YS |
Year: |
2022 |
Journal: |
Cell |
Title: |
Topical therapy for regression and melanoma prevention of congenital giant nevi. |
Volume: |
185 |
Issue: |
12 |
Pages: |
2071-2085.e12 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhang J |
Year: |
2017 |
Journal: |
Blood |
Title: |
p53-/- synergizes with enhanced NrasG12D signaling to transform megakaryocyte-erythroid progenitors in acute myeloid leukemia. |
Volume: |
129 |
Issue: |
3 |
Pages: |
358-370 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chang YI |
Year: |
2015 |
Journal: |
Leukemia |
Title: |
Loss of Dnmt3a and endogenous Kras(G12D/+) cooperate to regulate hematopoietic stem and progenitor cell functions in leukemogenesis. |
Volume: |
29 |
Issue: |
9 |
Pages: |
1847-56 |
|
•
•
•
•
•
|
Publication |
First Author: |
Dovey OM |
Year: |
2017 |
Journal: |
Blood |
Title: |
Molecular synergy underlies the co-occurrence patterns and phenotype of NPM1-mutant acute myeloid leukemia. |
Volume: |
130 |
Issue: |
17 |
Pages: |
1911-1922 |
|
•
•
•
•
•
|
Publication |
First Author: |
Weyandt JD |
Year: |
2016 |
Journal: |
PLoS One |
Title: |
Isoform-Specific Effects of Wild-Type Ras Genes on Carcinogen-Induced Lung Tumorigenesis in Mice. |
Volume: |
11 |
Issue: |
12 |
Pages: |
e0167205 |
|
•
•
•
•
•
|
Publication |
First Author: |
Nowacka JD |
Year: |
2016 |
Journal: |
Oncotarget |
Title: |
MEK1 is required for the development of NRAS-driven leukemia. |
Volume: |
7 |
Issue: |
49 |
Pages: |
80113-80130 |
|
•
•
•
•
•
|
Publication |
First Author: |
Threadgill DS |
Year: |
1994 |
Journal: |
Genomics |
Title: |
Syntenic assignment of human chromosome 1 homologous loci in the bovine. |
Volume: |
22 |
Issue: |
3 |
Pages: |
626-30 |
|
•
•
•
•
•
|
Publication |
First Author: |
van Tuyn J |
Year: |
2017 |
Journal: |
J Invest Dermatol |
Title: |
Oncogene-Expressing Senescent Melanocytes Up-Regulate MHC Class II, a Candidate Melanoma Suppressor Function. |
Volume: |
137 |
Issue: |
10 |
Pages: |
2197-2207 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gu Z |
Year: |
2019 |
Journal: |
Cancer Discov |
Title: |
Loss of EZH2 Reprograms BCAA Metabolism to Drive Leukemic Transformation. |
Volume: |
9 |
Issue: |
9 |
Pages: |
1228-1247 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ha L |
Year: |
2007 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
ARF functions as a melanoma tumor suppressor by inducing p53-independent senescence. |
Volume: |
104 |
Issue: |
26 |
Pages: |
10968-73 |
|
•
•
•
•
•
|
Publication |
First Author: |
To MD |
Year: |
2013 |
Journal: |
Oncogene |
Title: |
Interactions between wild-type and mutant Ras genes in lung and skin carcinogenesis. |
Volume: |
32 |
Issue: |
34 |
Pages: |
4028-33 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chen S |
Year: |
2022 |
Journal: |
Cancer Discov |
Title: |
Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation. |
Volume: |
12 |
Issue: |
10 |
Pages: |
2434-2453 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wen Z |
Year: |
2022 |
Journal: |
Leukemia |
Title: |
Tcof1 haploinsufficiency promotes early T cell precursor-like leukemia in NrasQ61R/+ mice. |
Volume: |
36 |
Issue: |
4 |
Pages: |
1167-1170 |
|
•
•
•
•
•
|
Publication |
First Author: |
Halaban R |
Year: |
2016 |
Journal: |
J Invest Dermatol |
Title: |
RASopathy Gene Mutations in Melanoma. |
Volume: |
136 |
Issue: |
9 |
Pages: |
1755-9 |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
Mus caroli |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|